Secondary Logo

Journal Logo

ERRATUM

Therapeutic Drug Monitoring: April 2004 - Volume 26 - Issue 2 - p 241
ERRATUM
Free

To the Editor:

In our 1999 TDM paper (Diav-Citrin et al: “An investigation into variability in the therapeutic response to deferiprone in patients with thalassemia major” (1), we indicated having received partial support from the Medical Research Council of Canada—Industry Program, but the specific industry sponsor, Apotex Inc. of Weston Ontario, was not referenced. We regret this oversight and acknowledge Apotex for its support.

Orna Diav-Citrin, Gordana Atanackovic, Gideon Koren Toronto and Jerusalem

Back to Top | Article Outline

Reference:

1) Diav-Citrin O, Atanackovic G, Koren G: An investigation into variability in the therapeutic response to deferiprone in patients with thalassemia major. Ther Drug Monit 1999;21:74-81
© 2004 Lippincott Williams & Wilkins, Inc.